Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Inhibition of HPV-16 E7 oncogenic activity by HPV- 16 E2 (CROSBI ID 228225)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Gammoh, Noor ; Isaacson, Erin ; Tomaić, Vjekoslav ; Jackson, Deborah J ; Doorbar, John ; Banks, Lawrence Inhibition of HPV-16 E7 oncogenic activity by HPV- 16 E2 // Oncogene, 28 (2009), 23; 2299-2304. doi: 10.1038/onc.2009.78

Podaci o odgovornosti

Gammoh, Noor ; Isaacson, Erin ; Tomaić, Vjekoslav ; Jackson, Deborah J ; Doorbar, John ; Banks, Lawrence

engleski

Inhibition of HPV-16 E7 oncogenic activity by HPV- 16 E2

Human papillomavirus (HPV) E7 is essential in inducing S-phase progression in differentiating epithelial cells. We have previously shown that HPV-16 E7 activity can be controlled by a direct interaction with the viral transcriptional activator E2, thereby inhibiting transforming potential of E7. We have extended these analyses to show that E2 induces a generalized re-localization of E7 within the cell nucleus, one potential consequence of which is the inhibition of E7- induced degradation of pRb. Most importantly, we show that E2 can also inhibit the ability of E7 to induce centrosome abnormalities, thus preventing aberrant mitoses. Taken together, these studies highlight the central importance of E2 in controlling the functions of E7, independently of the ability of E2 to regulate transcription.

HPV ; E7 ; centrosomes ; pRb

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

28 (23)

2009.

2299-2304

objavljeno

0950-9232

10.1038/onc.2009.78

Povezanost rada

Temeljne medicinske znanosti, Biologija

Poveznice
Indeksiranost